nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—SI—nervous system—attention deficit hyperactivity disorder	0.0213	0.101	CbGeAlD
Scopolamine—SI—central nervous system—attention deficit hyperactivity disorder	0.0205	0.0972	CbGeAlD
Scopolamine—SI—brain—attention deficit hyperactivity disorder	0.0163	0.0771	CbGeAlD
Scopolamine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.0105	0.0498	CbGeAlD
Scopolamine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0104	0.0493	CbGeAlD
Scopolamine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.0101	0.048	CbGeAlD
Scopolamine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00947	0.0448	CbGeAlD
Scopolamine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00879	0.0417	CbGeAlD
Scopolamine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00847	0.0401	CbGeAlD
Scopolamine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00822	0.039	CbGeAlD
Scopolamine—CHRM4—brain—attention deficit hyperactivity disorder	0.00804	0.0381	CbGeAlD
Scopolamine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.008	0.0379	CbGeAlD
Scopolamine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00792	0.0375	CbGeAlD
Scopolamine—CHRM5—brain—attention deficit hyperactivity disorder	0.00629	0.0298	CbGeAlD
Scopolamine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00565	0.0267	CbGeAlD
Scopolamine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00543	0.0257	CbGeAlD
Scopolamine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00514	0.0243	CbGeAlD
Scopolamine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00495	0.0234	CbGeAlD
Scopolamine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.0046	0.0218	CbGeAlD
Scopolamine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00443	0.021	CbGeAlD
Scopolamine—CHRM2—brain—attention deficit hyperactivity disorder	0.00431	0.0204	CbGeAlD
Scopolamine—CHRM1—brain—attention deficit hyperactivity disorder	0.00393	0.0186	CbGeAlD
Scopolamine—CHRM3—brain—attention deficit hyperactivity disorder	0.00351	0.0166	CbGeAlD
Scopolamine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00329	0.0156	CbGeAlD
Scopolamine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00279	0.0132	CbGeAlD
Scopolamine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00218	0.0103	CbGeAlD
Scopolamine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00179	0.00847	CbGeAlD
Scopolamine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00172	0.00816	CbGeAlD
Scopolamine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00168	0.00797	CbGeAlD
Scopolamine—ABCB1—brain—attention deficit hyperactivity disorder	0.00137	0.00648	CbGeAlD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000696	0.000882	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000694	0.00088	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00069	0.000874	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000688	0.000872	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000682	0.000865	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000681	0.000863	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00068	0.000862	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000668	0.000847	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000666	0.000844	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00066	0.000836	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000659	0.000835	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000657	0.000832	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000655	0.00083	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000653	0.000828	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000649	0.000822	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000648	0.000822	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000647	0.00082	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000646	0.000819	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000644	0.000817	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00064	0.000812	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000639	0.00081	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000638	0.000809	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000638	0.000809	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000637	0.000807	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000628	0.000797	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000628	0.000796	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000611	0.000775	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000604	0.000766	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000602	0.000763	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000601	0.000762	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000596	0.000756	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000572	0.000724	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00057	0.000722	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000565	0.000716	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000563	0.000714	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000558	0.000707	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000542	0.000687	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000538	0.000682	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000536	0.00068	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000531	0.000673	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000527	0.000668	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000525	0.000666	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000525	0.000666	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000524	0.000664	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00052	0.00066	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000519	0.000658	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000519	0.000657	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000509	0.000645	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000507	0.000643	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000502	0.000637	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0005	0.000634	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000499	0.000632	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000498	0.000632	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000494	0.000626	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000494	0.000626	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000494	0.000626	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000493	0.000624	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000492	0.000624	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000492	0.000624	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000492	0.000624	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000489	0.000619	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000488	0.000618	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000488	0.000618	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000487	0.000617	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000482	0.000611	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000479	0.000607	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000478	0.000606	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000477	0.000605	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000477	0.000605	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000474	0.0006	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000472	0.000599	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000471	0.000597	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00047	0.000596	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00046	0.000583	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000459	0.000581	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000458	0.00058	CbGpPWpGaD
Scopolamine—SI—Disease—EP300—attention deficit hyperactivity disorder	0.000454	0.000576	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000454	0.000576	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000454	0.000575	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00044	0.000558	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00043	0.000545	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00043	0.000545	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000429	0.000544	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000428	0.000543	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000426	0.000541	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000425	0.000538	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000423	0.000536	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000422	0.000535	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000422	0.000534	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000419	0.000532	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000419	0.000531	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000418	0.00053	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000414	0.000525	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000412	0.000522	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000411	0.000521	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00041	0.00052	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000408	0.000518	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000402	0.000509	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000401	0.000509	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0004	0.000507	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000396	0.000503	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000394	0.000499	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000387	0.000491	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000386	0.00049	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000386	0.000489	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000383	0.000485	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000381	0.000482	CbGpPWpGaD
Scopolamine—SI—Metabolism—EP300—attention deficit hyperactivity disorder	0.000381	0.000482	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000376	0.000477	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000371	0.00047	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000369	0.000468	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000365	0.000463	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000364	0.000462	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000364	0.000462	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000361	0.000457	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00036	0.000456	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00035	0.000444	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000344	0.000436	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000336	0.000426	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000335	0.000425	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000335	0.000424	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000332	0.000421	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000332	0.00042	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000331	0.000419	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000328	0.000415	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000322	0.000409	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000321	0.000407	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00032	0.000405	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000319	0.000405	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000318	0.000404	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000318	0.000403	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000315	0.0004	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000297	0.000376	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000296	0.000375	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000293	0.000371	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000291	0.000368	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00029	0.000368	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000289	0.000366	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000289	0.000366	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000288	0.000365	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000288	0.000364	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000287	0.000363	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000286	0.000363	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000285	0.000361	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000284	0.00036	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000283	0.000358	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000283	0.000358	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000282	0.000357	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000282	0.000357	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000279	0.000354	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000279	0.000354	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000279	0.000354	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000278	0.000353	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000278	0.000353	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000277	0.000351	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000276	0.00035	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000276	0.000349	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000274	0.000347	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00027	0.000342	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00027	0.000342	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000269	0.000341	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000266	0.000337	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000261	0.000331	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00026	0.00033	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00026	0.00033	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000259	0.000329	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000259	0.000328	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000258	0.000327	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000257	0.000325	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000257	0.000325	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000256	0.000324	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000254	0.000322	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000253	0.000321	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000253	0.000321	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000253	0.00032	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00025	0.000317	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000245	0.000311	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000243	0.000308	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000237	0.000301	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000237	0.000301	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000236	0.000299	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000236	0.000299	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000235	0.000298	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000235	0.000298	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000234	0.000296	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000233	0.000295	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000229	0.000291	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000229	0.00029	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000226	0.000287	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000225	0.000285	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000222	0.000281	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000219	0.000278	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000218	0.000277	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000217	0.000275	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000215	0.000273	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000213	0.00027	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000211	0.000267	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000207	0.000262	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000198	0.000251	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000196	0.000248	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000195	0.000248	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000193	0.000245	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00019	0.000241	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000182	0.000231	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000182	0.00023	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000181	0.000229	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00018	0.000228	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000171	0.000217	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000171	0.000216	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000169	0.000214	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000165	0.00021	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000165	0.000209	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000163	0.000207	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000159	0.000202	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000159	0.000201	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000157	0.000199	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000154	0.000196	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000154	0.000195	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000152	0.000193	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.000192	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.000192	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000151	0.000191	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000151	0.000191	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00015	0.00019	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00015	0.00019	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000149	0.000189	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000148	0.000188	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000148	0.000187	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000145	0.000184	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000144	0.000182	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000143	0.000181	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000139	0.000177	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000139	0.000176	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000139	0.000176	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000138	0.000175	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000138	0.000175	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00012	0.000153	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000115	0.000145	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.77e-05	0.000124	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.74e-05	0.000123	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.64e-05	0.000122	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	9.13e-05	0.000116	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.07e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.68e-05	9.73e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.35e-05	9.32e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	6.17e-05	7.82e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.18e-05	6.56e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.16e-05	6.54e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.11e-05	6.48e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.92e-05	4.96e-05	CbGpPWpGaD
